Krystal Biotech, Inc. (KRYS) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $58.42M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $53.69M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $41.37M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $39.40M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2022-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | $58.42M | (m) | $119.22M | (m) | $3.56M* | $74.79M* | (m) | $14.52M | $39.85M | $11.31M |
|---|
| 2026-03-31 | Reported | (m) | $53.69M | (m) | $116.36M | (m) | $7.15M | $80.38M | (m) | $15.33M | $41.01M | $5.51M |
|---|
| 2025-09-30 | Reported | (m) | $41.37M | (m) | $97.80M | (m) | $1.70M* | $39.66M* | (m) | $14.59M | $37.58M | -$31.40M |
|---|
| 2025-06-30 | Reported | (m) | $39.40M | (m) | $96.04M | (m) | $1.90M* | $52.73M* | (m) | $14.41M | $35.07M | $8.44M |
|---|
| 2025-03-31 | Reported | (m) | $36.25M | (m) | $88.18M | (m) | $6.20M | $30.97M | (m) | $14.26M | $32.65M | $7.86M |
|---|
| 2024-09-30 | Reported | (m) | $22.47M | (m) | $83.84M | (m) | $1.05M* | $58.86M* | (m) | $13.51M | $28.67M | $2.59M |
|---|
| 2024-06-30 | Reported | (m) | $8.57M | (m) | $70.28M | (m) | $1.13M* | -$4.17M* | (m) | $15.58M | $27.63M | $477.00K |
|---|
| 2024-03-31 | Reported | (m) | -$6.68M | (m) | $45.25M | (m) | $1.26M | $15.89M | (m) | $10.96M | $26.06M | $0.00 |
|---|
| 2023-09-30 | Reported | (m) | -$25.99M | (m) | $8.56M | (m) | $1.78M* | -$21.23M* | (m) | $10.63M | $23.70M | $0.00 |
|---|
| 2023-06-30 | Reported | (m) | -$38.05M | (m) | $0.00 | (m) | $2.79M* | -$34.19M* | (m) | $12.14M | $25.90M | $0.00 |
|---|
| 2023-03-31 | Reported | (m) | -$48.82M | (m) | $0.00 | (m) | $5.38M | -$26.16M | (m) | $12.29M | $24.04M | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$31.45M | (m) | $0.00 | (m) | $14.06M* | -$19.69M* | (m) | $11.52M | $19.93M | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$28.75M | (m) | (m) | (m) | $16.52M* | -$43.06M* | (m) | $10.89M | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$50.22M | (m) | (m) | (m) | $17.19M | -$15.49M | (m) | $9.31M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$15.65M | (m) | (m) | (m) | $20.99M* | -$7.25M* | (m) | $6.08M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$16.39M | (m) | (m) | (m) | $3.99M* | -$10.13M* | (m) | $6.59M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$14.35M | (m) | (m) | (m) | $2.47M | -$9.65M | (m) | $6.20M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$9.68M | (m) | (m) | (m) | $4.18M* | -$6.78M* | (m) | $5.10M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$6.95M | (m) | (m) | (m) | $1.95M* | -$5.05M* | (m) | $3.64M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$5.95M | (m) | (m) | (m) | $1.51M | -$6.23M | (m) | $3.52M | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$5.34M | (m) | (m) | (m) | $1.18M* | -$4.27M* | (m) | $3.88M | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$5.89M | (m) | (m) | (m) | $1.24M* | -$4.21M* | (m) | $4.22M | (m) | (m) |
|---|
| 2019-03-31 | Reported | (m) | -$4.69M | (m) | (m) | (m) | $1.71M | -$3.21M | (m) | $3.17M | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$2.97M | (m) | (m) | (m) | $832.00K* | -$1.94M* | (m) | $1.91M | (m) | (m) |
|---|
| 2018-06-30 | Reported | (m) | -$2.45M | (m) | (m) | (m) | (m) | -$1.62M* | (m) | $1.52M | (m) | (m) |
|---|
| 2018-03-31 | Reported | (m) | -$2.28M | (m) | (m) | (m) | (m) | -$2.37M | (m) | $1.52M | (m) | (m) |
|---|
| 2017-09-30 | Reported | (m) | -$2.09M | (m) | (m) | (m) | $12.00K* | -$1.10M* | (m) | $1.35M | (m) | (m) |
|---|
| 2017-06-30 | Reported | (m) | -$715.00K | (m) | (m) | (m) | $32.00K* | (m) | (m) | $446.00K | (m) | (m) |
|---|
| 2017-03-31 | Reported | (m) | -$465.00K | (m) | (m) | (m) | $7.00K | (m) | (m) | $319.00K | (m) | (m) |
|---|
| 2016-09-30 | Reported | (m) | -$322.00K | (m) | (m) | (m) | (m) | (m) | (m) | $241.00K | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | $161.29M | (m) | $389.13M | (m) | $11.95M | $200.87M | (m) | $58.05M | $146.74M | -$15.36M |
|---|
| 2024-12-31 | Reported | (m) | $65.75M | (m) | $290.51M | (m) | $4.24M | $123.42M | (m) | $53.58M | $113.63M | $6.20M |
|---|
| 2023-12-31 | Reported | (m) | -$109.62M | (m) | $50.70M | (m) | $11.80M | -$88.80M | (m) | $46.43M | $98.29M | $1.97M |
|---|
| 2022-12-31 | Reported | -$141.14M | (m) | (m) | (m) | (m) | $52.98M | -$100.57M | (m) | $42.46M | $77.73M | $0.00 |
|---|
| 2021-12-31 | Reported | -$65.51M | (m) | (m) | (m) | (m) | $68.34M | -$47.94M | (m) | $27.88M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$31.15M | (m) | (m) | (m) | (m) | $14.84M | -$26.08M | (m) | $17.94M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$20.99M | (m) | (m) | (m) | (m) | $6.40M | -$18.69M | (m) | $15.62M | (m) | $0.00 |
|---|
| 2018-12-31 | Reported | (m) | -$11.92M | (m) | (m) | (m) | $2.23M | -$9.45M | (m) | $7.76M | (m) | $0.00 |
|---|
| 2017-12-31 | Reported | (m) | -$4.77M | (m) | (m) | (m) | $210.00K | (m) | (m) | $3.21M | (m) | $0.00 |
|---|
| 2016-12-31 | Reported | (m) | -$1.14M | (m) | (m) | (m) | $15.00K | (m) | (m) | $741.00K | (m) | (m) |
|---|